Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : DE0005785802
Share Class Description:
FMCQF: Ordinary SharesCompare
Compare
Traded in other countries / regions
FME.GermanyFMS.USA0H9X.UK1FME.ItalyFME.AustriaFMSC34.BrazilFME.Mexico IPO Date
2009-11-16Description
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | 4.41 | |||||
| Interest Coverage | 4.33 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 1.77 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | -8 | |||||
| 3-Year EPS without NRI Growth Rate | -17.1 | |||||
| 3-Year FCF Growth Rate | -15.1 | |||||
| 3-Year Book Growth Rate | 6.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.11 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.27 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 100 | |||||
| 14-Day RSI | 99.91 | |||||
| 3-1 Month Momentum % | 2.25 | |||||
| 6-1 Month Momentum % | -7.12 | |||||
| 12-1 Month Momentum % | -2.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 55.88 | |||||
| Days Sales Outstanding | 70.84 | |||||
| Days Payable | 20.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.68 | |||||
| Dividend Payout Ratio | 0.45 | |||||
| 3-Year Dividend Growth Rate | -2.3 | |||||
| Forward Dividend Yield % | 2.68 | |||||
| 5-Year Yield-on-Cost % | 3.02 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 12.81 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.13 | |||||
| Operating Margin % | 9.4 | |||||
| Net Margin % | 3.43 | |||||
| FCF Margin % | 8.71 | |||||
| ROE % | 4.77 | |||||
| ROA % | 1.93 | |||||
| ROIC % | 4.12 | |||||
| 3-Year ROIIC % | -33.37 | |||||
| ROC (Joel Greenblatt) % | 18.86 | |||||
| ROCE % | 5.87 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.21 | |||||
| Forward PE Ratio | 13.22 | |||||
| PE Ratio without NRI | 17.36 | |||||
| Shiller PE Ratio | 10.88 | |||||
| Price-to-Owner-Earnings | 6.97 | |||||
| PS Ratio | 0.69 | |||||
| PB Ratio | 0.98 | |||||
| Price-to-Free-Cash-Flow | 8.01 | |||||
| Price-to-Operating-Cash-Flow | 5.87 | |||||
| EV-to-EBIT | 14.67 | |||||
| EV-to-Forward-EBIT | 11.07 | |||||
| EV-to-EBITDA | 9.47 | |||||
| EV-to-Forward-EBITDA | 7.28 | |||||
| EV-to-Revenue | 1.25 | |||||
| EV-to-Forward-Revenue | 1.19 | |||||
| EV-to-FCF | 14.43 | |||||
| Price-to-GF-Value | 1.23 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Median-PS-Value | 0.57 | |||||
| Earnings Yield (Greenblatt) % | 6.82 | |||||
| FCF Yield % | 12.45 | |||||
| Forward Rate of Return (Yacktman) % | 4.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:FMCQF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fresenius Medical Care AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20,987.676 | ||
| EPS (TTM) ($) | 2.458 | ||
| Beta | 0.8 | ||
| 3-Year Sharpe Ratio | -0.25 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 24.49 | ||
| 14-Day RSI | 99.91 | ||
| 14-Day ATR ($) | 0.460766 | ||
| 20-Day SMA ($) | 41.914 | ||
| 12-1 Month Momentum % | -2.99 | ||
| 52-Week Range ($) | 35.45 - 48.19 | ||
| Shares Outstanding (Mil) | 293.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fresenius Medical Care AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fresenius Medical Care AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fresenius Medical Care AG Frequently Asked Questions
What is Fresenius Medical Care AG(FMCQF)'s stock price today?
The current price of FMCQF is $47.58. The 52 week high of FMCQF is $48.19 and 52 week low is $35.45.
When is next earnings date of Fresenius Medical Care AG(FMCQF)?
The next earnings date of Fresenius Medical Care AG(FMCQF) is 2025-02-20 Est..
Does Fresenius Medical Care AG(FMCQF) pay dividends? If so, how much?
The Dividend Yield %  of Fresenius Medical Care AG(FMCQF) is 2.68% (As of Today), Highest Dividend Payout Ratio of Fresenius Medical Care AG(FMCQF) was 0.5. The lowest was 0.22. And the median was 0.28. The  Forward Dividend Yield % of Fresenius Medical Care AG(FMCQF) is 2.68%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers